Dora: A randomized phase II multicenter maintenance study of olaparib alone or olaparib in combination with durvalumab in platinum responsive advanced triple-negative breast cancer (aTNBC) Meeting Abstract
| Authors: | Sammons, S.; Tan, T. J. Y.; Traina, T. A.; Kim, S. B.; Im, Y. H.; Bachelder, C.; Marcom, P. K.; Dent, R. A. |
| Abstract Title: | Dora: A randomized phase II multicenter maintenance study of olaparib alone or olaparib in combination with durvalumab in platinum responsive advanced triple-negative breast cancer (aTNBC) |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 62s |
| Language: | English |
| ACCESSION: | WOS:000487345803239 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.TPS1113 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS1113 -- Source: Wos |
